Pao-Hsien Chu

Prof. Dr. Pao-Hsien Chu

Cardiology, Chang Gung Memorial Hospital, Taoyuan City, Taiwan
orcid
Director, Institute of Stem Cell and Translational Cancer Re...

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2003 in Developmental Cell
Verified
Journal Article
Closed access
CCChen-Leng Cai
Chen-Leng Cai
XLXingqun Liang
Xingqun Liang
YSYunqing Shi
Yunqing Shi
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
SPSamuel L Pfaff
Samuel L Pfaff
SESylvia Evans
Sylvia Evans

12 August 2002 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
YZYouyang Zhao
Youyang Zhao
YLYang Liu
Yang Liu
RSRadu V Stan
Radu V Stan
LFLian Fan
Lian Fan
YGYusu Gu
Yusu Gu
KCKenneth R. Chien
Kenneth R. Chien
Caveolins are important components of caveolae, which have been implicated in vesicular trafficking and signal transduction. To investigate the in vivo significance of Caveolins in mammals, we generated mice deficient in the caveolin-1 ( cav-1 ) gene and have shown that, in the absence of Cav-1, no caveolae structures were observed in several nonmuscle cell types. Although cav-1 −/− mice are viable, histological examination and echocardiography identified a spectrum of characteristics of dilated cardiomyopathy in the left ventricular chamber of the cav-1 -deficient hearts, including an enlarged ventricular chamber diameter, thin posterior wall, and decreased contractility. These animals also have marked right ventricular hypertrophy, suggesting a chronic increase in pulmonary artery pressure. Direct measurement of pulmonary artery pressure and histological analysis revealed that the cav-1 −/− mice exhibit pulmonary hypertension, which may contribute to the right ventricle hypertrophy. In addition, the loss of Cav-1 leads to a dramatic increase in systemic NO levels. Our studies provided in vivo evidence that cav-1 is essential for the control of systemic NO levels and normal cardiopulmonary function.

1 December 2001 in Cell
Verified
Journal Article
Closed access
HKHai-Chien Kuo
Hai-Chien Kuo
Ching-Feng ChengChing-Feng Cheng
Ching-Feng Cheng
RCRobert B. Clark
Robert B. Clark
JLJim J.-C. Lin
Jim J.-C. Lin
JLJenny L.-C. Lin
Jenny L.-C. Lin
KCKenneth R. Chien
Kenneth R. Chien

1 January 2005 in Cell
Verified
Journal Article
Closed access
XXXiangdong Xu
Xiangdong Xu
DYDongmei Yang
Dongmei Yang
JDJian-Hua Ding
Jian-Hua Ding
WWWang Wang
Wang Wang
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
XFXiang-Dong Fu
Xiang-Dong Fu

5 November 2001 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
QZQiang Zhou
Qiang Zhou
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
CHChenqun Huang
Chenqun Huang
Ching-Feng ChengChing-Feng Cheng
Ching-Feng Cheng
MMMaryann E. Martone
Maryann E. Martone
JCJu Chen
Ju Chen
Cypher is a member of a recently emerging family of proteins containing a PDZ domain at their NH2 terminus and one or three LIM domains at their COOH terminus. Cypher knockout mice display a severe form of congenital myopathy and die postnatally from functional failure in multiple striated muscles. Examination of striated muscle from the mutants revealed that Cypher is not required for sarcomerogenesis or Z-line assembly, but rather is required for maintenance of the Z-line during muscle function. In vitro studies demonstrated that individual domains within Cypher localize independently to the Z-line via interactions with α-actinin or other Z-line components. These results suggest that Cypher functions as a linker-strut to maintain cytoskeletal structure during contraction.

1 December 2008 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
FSFarah Sheikh
Farah Sheikh
ARAnna Raskin
Anna Raskin
Pao-Hsien ChuPao-Hsien Chu
Pao-Hsien Chu
SLStephan Lange
Stephan Lange
ADAndrea A. Domenighetti
Andrea A. Domenighetti
JCJu Chen
Ju Chen
The response of cardiomyocytes to biomechanical stress can determine the pathophysiology of hypertrophic cardiac disease, and targeting the pathways regulating these responses is a therapeutic goal. However, little is known about how biomechanical stress is sensed by the cardiomyocyte sarcomere to transduce intracellular hypertrophic signals or how the dysfunction of these pathways may lead to disease. Here, we found that four-and-a-half LIM domains 1 (FHL1) is part of a complex within the cardiomyocyte sarcomere that senses the biomechanical stress–induced responses important for cardiac hypertrophy. Mice lacking Fhl1 displayed a blunted hypertrophic response and a beneficial functional response to pressure overload induced by transverse aortic constriction. A link to the Gαq (Gq) signaling pathway was also observed, as Fhl1 deficiency prevented the cardiomyopathy observed in Gq transgenic mice. Mechanistic studies demonstrated that FHL1 plays an important role in the mechanism of pathological hypertrophy by sensing biomechanical stress responses via the N2B stretch sensor domain of titin and initiating changes in the titin- and MAPK-mediated responses important for sarcomere extensibility and intracellular signaling. These studies shed light on the physiological regulation of the sarcomere in response to hypertrophic stress.